Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE3
The primary objective of the study was to evaluate whether progression-free...
Status
Terminated
Location
University of Alabama at Birmingham - Main /ID# 138087
Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer
PHASE1
The study seeks to assess the efficacy of veliparib (ABT-888) in combinatio...
A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC)
PHASE1
This study seeks to establish
* the recommended Phase 2 dose (RPTD) of vel...
A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer
PHASE3
This is a 3 arm Phase 3 study to evaluate the safety and efficacy of the ad...
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
PHASE2
This randomized phase II trial studies how well cisplatin works with or wit...